Share Name Share Symbol Market Type Share ISIN Share Description
Ovoca Gold LSE:OVG London Ordinary Share IE00B4XVDC01 EUR0.125
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 10.25p 9.50p 11.00p - - - 0 05:30:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining 0.0 -0.3 -0.4 - 8.36

Ovoca Gold Share Discussion Threads

Showing 13001 to 13021 of 13025 messages
Chat Pages: 521  520  519  518  517  516  515  514  513  512  511  510  Older
DateSubjectAuthorDiscuss
05/7/2018
00:05
Why is the chart flat-lining this afternoon?
fenners66
04/7/2018
13:30
Hazel,the master of misinformation, posting after a long absence even though she does not hold.
fiachra
04/7/2018
09:27
https://youtu.be/8hDJxHjqKZo
bob1995
04/7/2018
09:24
https://www.youtube.com/channel/UC_kJKW8zB8X00rAbsbPaiJQ
bob1995
04/7/2018
09:17
I don’t regret selling, i sold based on my own concerns following several interactions with the company. If I had still held I would have sold this AM having read the RNS, irrespective of the rise. I am unconvinced and skeptical about today’s announcement.
oli12
04/7/2018
08:53
Well I have read the whole RNS and there is Nothing in there that says this is an arms length transaction.......
fenners66
04/7/2018
08:52
The Company operates a share option plan which was adopted on 20 July 2009 and which gives employees, directors and consultants of companies within the Group the opportunity to acquire shares in the Company. The Remuneration Committee will consider a timetable for proposed awards following Admission WHAT ?! They have been doing NOTHING for the last 9 years !!!
fenners66
04/7/2018
08:51
" Remuneration committee The remuneration committee will be chaired with effect from Admission by Mikhail Mogutov with Leonid Skoptsov being the other member of the committee. It is expected to meet not less than two times a year. Directors may attend meetings at the committee's invitation. The remuneration committee has responsibility for determining, within agreed terms of reference, the Enlarged Group's policy on the remuneration of senior executives and specific remuneration packages for executive Directors, including pension rights and compensation payments. It is also responsible for selecting individuals to whom to make grants of awards under the Share Option Scheme. " haha the enlarged group will have enlarged directors' remuneration no doubt and we know they give out cash just for attending the meetings .... to work out how much cash they will be giving out.....
fenners66
04/7/2018
08:47
How come after all these years they now want to tell us about the Directors' backgrounds ?
fenners66
04/7/2018
08:43
OIL12 I told you you shouldn't let bitter stale-bulls frighten you off. (NOT A CURRENT HOLDER)
hazl
04/7/2018
08:43
They go on to talk about other treatments that failed and other deals that are now commercial failure and subject to litigation...which is to try and say there is no competition However does it also point the way to similar outcomes here ?
fenners66
04/7/2018
08:40
"Since 31 December 2017, Ovoca has traded in line with management expectations. Mining and exploration operations remain suspended at the Company's licence areas in Russia" "During the remainder of 2018, the Company will continue to rigorously pursue all available legal options to recover amounts due to it pursuant to the loans previously extended to Taymura LLC, including the pursuit of the personal guarantees which were used to secure the loan. However, there can be no guarantee that the entire loan amount will be recovered by Ovoca. " Tell us something we did not know years ago
fenners66
04/7/2018
08:39
A CERTAIN MULTI BAGGER GUYS, WELLDONE
alia
04/7/2018
08:36
Worth billions possibly.. Wow
letmepass
04/7/2018
08:34
"but there can be no guarantee that a patent will be granted on foot of such applications"
fenners66
04/7/2018
08:34
The next viagra
letmepass
04/7/2018
08:29
Please keep buying. My sell order is being filled as we speak.
jeevsje
04/7/2018
08:16
"initiate a first-in-human clinical study in early 2015." I'm sure it was fnar fnar..........
fenners66
04/7/2018
08:09
You called this spot on fenners.
oli12
04/7/2018
08:05
Not got far enough into the announcement to find out whether it is a linked or 3rd party transaction.
fenners66
04/7/2018
08:03
"It now intends to complete the Russian Phase III clinical trial for Libicore in Q3 2019 and expects to have the results available by Q2 2019," Ha Ha the Soviet election results are strong with this one....... Results available Q2 2019 but the tests will not be done until Q3 2019...... haha
fenners66
Chat Pages: 521  520  519  518  517  516  515  514  513  512  511  510  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180923 10:05:11